5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.03▼ | 2.02▲ | 2.02▲ | 2.06▼ | 1.94▲ |
MA10 | 2.03▼ | 2.02▲ | 2.02▲ | 2.00▲ | 1.70▲ |
MA20 | 2.02▲ | 2.02▲ | 2.03▼ | 1.94▲ | 1.54▲ |
MA50 | 2.02▲ | 2.06▼ | 2.05▼ | 1.66▲ | 1.45▲ |
MA100 | 2.02▲ | 2.03▼ | 1.94▲ | 1.52▲ | 1.23▲ |
MA200 | 2.05▼ | 1.93▲ | 1.87▲ | 1.43▲ | 1.55▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.003▲ | -0.002▼ | -0.002▼ | 0.068▲ |
RSI | 52.611▲ | 48.561▼ | 47.853▼ | 62.133▲ | 65.305▲ |
STOCH | 61.111 | 62.963 | 62.222 | 76.242 | 84.575▲ |
WILL %R | -40.000 | -30.000 | -41.667 | -35.714 | -16.129▲ |
CCI | 7.179 | 59.048 | 56.195 | 44.284 | 123.672▲ |
▼ MACD | $AKBA MACD(12,26,9) Crossed Below Signal Line | Set Alert |
Wednesday, November 27, 2024 01:41 AM
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Akebia Therapeutics, Inc. AKBA is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings ...
|
Thursday, November 14, 2024 05:00 AM
CAMBRIDGE, Mass., Nov. 14, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease ...
|
Wednesday, November 13, 2024 04:00 PM
Shares of NASDAQ:AKBA opened at $1.92 on Monday. The firm has a market cap of $418.91 million, a PE ratio of -8.35 and a beta of 0.74. The company’s 50 day moving average price is $1.48 and its ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
05/12/24 | 2.03 | 2.04 | 1.99 | 2.02 | 1,246,081 |
04/12/24 | 2.05 | 2.06 | 1.99 | 2.03 | 1,625,444 |
03/12/24 | 2.13 | 2.17 | 2.01 | 2.04 | 3,342,659 |
02/12/24 | 2.08 | 2.16 | 2.04 | 2.13 | 2,438,605 |
29/11/24 | 2.07 | 2.13 | 2.06 | 2.06 | 2,135,763 |
27/11/24 | 2.05 | 2.08 | 2.03 | 2.06 | 1,623,027 |
26/11/24 | 1.93 | 2.10 | 1.90 | 2.05 | 3,908,126 |
25/11/24 | 1.90 | 1.97 | 1.88 | 1.93 | 2,553,145 |
22/11/24 | 1.84 | 1.8995 | 1.805 | 1.88 | 2,012,364 |
21/11/24 | 1.81 | 1.83 | 1.75 | 1.82 | 1,444,269 |
|
|
||||
|
|
||||
|
|